Completed NA INTERVENTIONAL 2-arm NCT01780714

Exploratory THS 2.1 Biomarkers of Exposure Study (ZRHX-EX-01)

A Single-center, Open-label, Randomized, Controlled, 2-arm Parallel Group Study to Evaluate the Exposure to Selected Smoke Constituents in Smoking, But Otherwise Healthy Subjects Switching From Conventional Cigarettes to the Tobacco Heating System (THS) 2.1

Sponsor: Philip Morris Products S.A.

Conditions Smoking

Interventions Conventional cigarettes (CC) THS 2.1

Updated 6 times since 2017 Last updated: Nov 18, 2019 Started: Jun 30, 2012 Primary completion: Jul 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Smoking, this trial is completed. The trial is conducted by Philip Morris Products S.A. and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Dec 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Philip Morris Products S.A.

Data source: Philip Morris Products S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland